Characterization of pumpkin polysaccharides and protective effects on streptozotocin-damaged islet cells

Chinese Journal of Natural Medicines

Volumn 13, Issue 3, 2015, Pages 199-207

  Zhu, Hong Yan ^a   Chen, Guang Tong ^a   Meng, Guo Liang ^a   Xu, Ji Liang ^a  

^a NANTONG MEDICAL COLLEGE   (China)

Author keywords

Antiapoptotic action; Antioxidant activity; Polysaccharides; Pumpkin; Streptozotocin

Indexed keywords

ANTIDIABETIC AGENT; ARABINOSE; CYTOPROTECTIVE AGENT; GALACTOSE; GLUCOSE; MALONALDEHYDE; MANNOSE; MESSENGER RNA; NITRIC OXIDE; POLYSACCHARIDE; PROTEIN BAX; PROTEIN BCL 2; STREPTOZOCIN; SUPEROXIDE DISMUTASE; MONOSACCHARIDE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANION EXCHANGE CHROMATOGRAPHY; ANTIDIABETIC ACTIVITY; APOPTOSIS; ARTICLE; CELL PROTECTION; COLUMN CHROMATOGRAPHY; CONTROLLED STUDY; CYTOTOXICITY; DIABETES MELLITUS; DRUG SCREENING; FRUIT; GAS CHROMATOGRAPHY; GEL FILTRATION CHROMATOGRAPHY; IN VITRO STUDY; INFRARED RADIATION; INFRARED SPECTROSCOPY; MOLECULAR WEIGHT; NONHUMAN; NUCLEAR MAGNETIC RESONANCE; OXIDATIVE STRESS; PANCREAS ISLET CELL; PHYSICAL CHEMISTRY; PROTON NUCLEAR MAGNETIC RESONANCE; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SQUASH; ANIMAL; BIOSYNTHESIS; CHEMISTRY; DIABETES MELLITUS, EXPERIMENTAL; DRUG EFFECTS; INJURIES; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PANCREAS ISLET; SIZE EXCLUSION CHROMATOGRAPHY; SPRAGUE DAWLEY RAT;

ANIMALS; APOPTOSIS; BCL-2-ASSOCIATED X PROTEIN; CHROMATOGRAPHY, GAS; CHROMATOGRAPHY, GEL; CUCURBITA; DIABETES MELLITUS, EXPERIMENTAL; ISLETS OF LANGERHANS; MAGNETIC RESONANCE SPECTROSCOPY; MALONDIALDEHYDE; MOLECULAR WEIGHT; MONOSACCHARIDES; NITRIC OXIDE; POLYSACCHARIDES; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; SUPEROXIDE DISMUTASE;

EID: 84933506813     PISSN: 20956975     EISSN: 18755364     Source Type: Journal    
DOI: 10.1016/S1875-5364(15)30005-4     Document Type: Article

References (37)

1. Alberti KG, Zimmet P, Shaw J Metabolic syndrome-a new worldwide definition. A consensus statement from the International Diabetes Federation [J]. Diabetic Med 2006, 23(5):469-480.
2. Fowler MJ Diabetes: Magnitude and Mechanisms [J]. Clin Diabetes 2010, 28(1):42-46.
3. Fu CL, Shi H, Li QH A review on pharmacological activities and utilization technologies of pumpkin [J]. Plant Food Hum Nutr 2006, 61(2):73-80.
4. Xia T, Wang Q Antihyperglycemic effect of Cucurbita ficifolia fruit extract in streptozotocin-induced diabetic rats [J]. Fitoterapia 2006, 77(7-8):530-533.
5. Ceriello A, Motz E Is oxidative stress the pathogenic mechanism underlying insulin resistance, diabetes, and cardiovascular disease? The common soil hypothesis revisited [J]. Arterioscl Throm Vas 2004, 24(5):816-823.
6. Evans JL, Goldfine ID, Maddux BA, et al. Are oxidative stress-activated signaling pathways mediators of insulin resistance and beta-cell dysfunction [J]. Diabetes 2003, 52(1):1-8.
7. Gopaul NK, Manraj MD, Hébé A, et al. Oxidative stress could precede endothelial dysfunction and insulin resistance in Indian Mauritians with impaired glucose metabolism [J]. Diabetologia 2001, 44(6):706-712.
8. Baynes JW Role of oxidative stress in development of complications in diabetes [J]. Diabetes 1991, 40(4):405-412.
9. Evans JL, Goldfine ID, Maddux BA, et al. Oxidative stress and stress-activated signaling pathways: a unifying hypothesis of type 2 diabetes [J]. Endocr Rev 2002, 23(5):599-622.
10. Vijayalingam S, Parthiban A, Shanmugasundaram KR, et al. Abnormal antioxidant status in impaired glucose tolerance and non-insulin-dependent diabetes mellitus [J]. Diabetic Med 1996, 13(8):715-719.
11. Lenzen S Oxidative stress: the vulnerable beta-cell [J]. Biochem Soc Trans 2008, 36(Pt 3):343-347.
12. Tiedge M, Lortz S, Drinkgern J, et al. Relation between antioxidant enzyme gene expression and antioxidative defense status of insulin-producing cells [J]. Diabetes 1997, 46(11):1733-1742.
13. Elmore S Apoptosis: a review of programmed cell death [J]. Toxicol Pathol 2007, 35(4):495-516.
14. Green DR Apoptotic pathways: ten minutes to dead [J]. Cell 2005, 121(5):671-674.
15. Chen Y, Xie MY, Nie SP, et al. Purification, composition analysis and antioxidant activity of a polysaccharide from the fruiting bodies of Ganoderma atrum [J]. Food Chem 2008, 107(1):231-241.
16. Liu DH, Gu WY Fractionation and structure of polysaccharides of Artemisia sphaerocephala Krasch gum [J]. Food Sci 2007, 28(3):73-76.
17. Zou S, Zhang X, Yao WB, et al. Structure characterization and hypoglycemic activity of a polysaccharide isolated from the fruit of Lycium barbarum L [J]. Carbohyd Polym 2010, 80(4):1161-1167.
18. Cui SW Structural analysis of polysaccharides. Food carbohydrates: Chemistry, physical properties, and applications [M] 2005, 153-161. CRC Press, Boca Raton, FL, USA. S.W. Cui (Ed.).
19. He JZ, Shao P, Men XH, et al. Analysis of structural characteristics of polysaccharide from Ganoderma Lucidum [J]. Chin J Anal Chem 2010, 38(7):372-376.
20. Wang Y, Yin HP, Lv XB, et al. Protection of chronic renal failure by a polysaccharide from Cordyceps sinensis [J]. Fitoterapia 2010, 81(5):397-402.
21. Roy SK, Das D, Mondal S, et al. Structural studies of an immunoenhancing water-soluble glucan isolated from hotwater extract of an edible mushroom, Pleurotus florida, cultivar Assam Florida [J]. Carbohyd Res 2009, 344(18):2596-2601.
22. Hikino H, Ishiyama M, Suzuki Y, et al. Mechanisms of hypoglycemic activity of ganoderan B: A glycan of Ganoderma lucidum fruit body [J]. Planta Med 1989, 55(5):423-428.
23. Hikino H, Konno C, Mirin Y, et al. Isolation and hypoglycemic activity of ganoderans A and B, glycans of Ganoderma lucidum fruit bodies [J]. Planata Med 1985, 51(4):339-340.
24. Jia J, Zhang X, Hu YS, et al. Evaluation of in vivo antioxidant activities of Ganoderma lucidum polysaccharides in STZ-diabetic rats [J]. Food Chem 2009, 115(1):32-36.
25. Bolzán AD, Bianchi MS Genotoxicity of streptozotocin [J]. Mutat Res 2002, 512(2-3):121-134.
26. Cheon H, Cho JM, Kim S, et al. Role of JNK activation in pancreatic β-cell death by streptozotocin [J]. Mol Cell Endocrinol 2010, 321(2):131-137.
27. Gao Y, Parker GJ, Hart GW Streptozotocin-induced β-cell death is independent of its inhibition of O-GlcNAcase in pancreatic Min6 cells [J]. Arch Biochem Biophys 2000, 383(2):296-302.
28. Rerup CC Drugs producing diabetes through damage of the insulin secreting cells [J]. Pharmacol Rev 1970, 22(4):485-518.
29. Rerup C, Tarding F Streptozotocin- and alloxan-diabetes in mice [J]. Eur J Pharmacol 1969, 7(1):89-96.
30. Zamzami N, Marchetti P, Castedo M, et al. Sequential reduction of mitochondrial transmembrane potential and generation of reactive oxygen species in early programmed cell death [J]. J Exp Med 1995, 182(2):367-377.
31. Halliwell B, Gutteridge JMC Free Radicals in Biology and Medicine [M] 1989, 86-106. Clarendon Press, Oxford, UK.
32. Anqqård E Nitric oxide: mediator, murderer, and medicine [J]. Lancet 1994, 343(8907):1199-1206.
33. Hengartner MO The biochemistry of apoptosis [J]. Nature 2000, 407(6805):770-776.
34. Que FG, Gores GJ Cell death by apoptosis: basic concepts and disease relevance for the gastroenterologist [J]. Gastroenterology 1996, 110(4):1238-1243.
35. Green DR, Reed JC Mitochondria and apoptosis [J]. Science 1998, 281(5381):1309-1312.
36. Anarkooli IJ, Sankian M, Ahmadpour S, et al. Evaluation of bcl-2 family gene expression and caspase-3 activity in hippocampus STZ-induced diabetic rats [J]. Exp Diabetes Res 2008, 2008:638467.
37. Yang B, Johnson TS, Thomas GL, et al. A shift in the Bax/Bcl-2 balance may activate caspase-3 and modulate apoptosis in experimental glomerulonephritis [J]. Kidney Int 2002, 62(4):1301-1313.